Does early improvement in depressive symptoms predict subsequent remission in patients with depression who are treated with duloxetine?

por Sueki A, Suzuki E, Takahashi H, Ishigooka J
Publicado 2016

A retrospective study of predictive factors for effective aripiprazole augmentation of antidepressant therapy in treatment-resistant depression

por Sugawara H, Sakamoto K, Harada T, Shimizu S, Ishigooka J
Publicado 2016

A prospective naturalistic study of antidepressant-induced jitteriness/anxiety syndrome

por Harada T, Inada K, Yamada K, Sakamoto K, Ishigooka J
Publicado 2014

Long-Term Efficacy and Safety of Brexpiprazole in Elderly Japanese Patients with Schizophrenia: A Subgroup Analysis of an Open-Label Study

por Inada K, Yamada S, Akiyoshi H, Kojima Y, Iwashita S, Ishigooka J
Publicado 2020

Identifying predictive clinical characteristics of the treatment efficacy of mirtazapine monotherapy for major depressive disorder

por Tsutsumi T, Sugawara H, Ito R, Asano M, Shimizu S, Ishigooka J, Nishimura K
Publicado 2016

Association between anxious distress in a major depressive episode and bipolarity

por Sugawara H, Tsutsumi T, Inada K, Ishigooka J, Hashimoto M, Takebayashi M, Nishimura K
Publicado 2019

Patient and Physician Perspectives of Depressive Symptoms and Expectations for Treatment Outcome: Results from a Web-Based Survey

por Ishigooka J, Hoshino T, Imai T, Yoshida H, Ono M, Ota M, Moriguchi Y, Fujikawa K, Shintani A, Fernandez JL
Publicado 2021

Safety and Effectiveness of Lurasidone in Patients with Schizophrenia: A 12-Week, Open-Label Extension Study

por Iyo M, Ishigooka J, Nakamura M, Sakaguchi R, Okamoto K, Mao Y, Tsai J, Fitzgerald A, Takai K, Higuchi T
Publicado 2021